Coho Partners, Ltd. Abb Vie Inc. Transaction History

Coho Partners, Ltd.

$2.71 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	BUY	$138.31 - $165.87 $202,485 - $242,833	1,464 New	1,464 $237,000
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $2,111 - $2,620	-16 Reduced 1.03%	1,531 $248,000
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $166,194 - $210,283	1,547 New	1,547 $209,000
Q3 2021 Oct 20, 2021	SELL	$106.4 - $120.78 $229,079 - $260,039	-2,153 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$105.21 - $117.21 $226,517 - $252,353	2,153 New	2,153 $243,000
Q1 2021 Apr 20, 2021	SELL	$102.3 - $112.62 $228,640 - $251,705	-2,235 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$80.49 - $108.67 $179,895 - $242,877	2,235 New	2,235 $239,000
Q3 2020 Nov 02, 2020	SELL	$85.91 - $100.83 $203,434 - $238,765	-2,368 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $173,740 - $232,490	2,368 New	2,368 $232,000
Q1 2020 Apr 27, 2020	SELL	$64.5 - $97.79 $152,736 - $231,566	-2,368 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $170,803 - $213,712	2,368 New	2,368 $210,000
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $166,221 - $212,469	-2,530 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$77.14 - $90.79 $848 - $998	-11 Reduced 0.43%	2,530 $204,000
Q3 2018 Oct 29, 2018	BUY	$88.91 - $98.84 $4,712 - $5,238	53 Added 2.13%	2,541 $240,000
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $10,055 - $11,897	-112 Reduced 4.31%	2,488 $231,000
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $1,932 - $2,587	-21 Reduced 0.8%	2,600 $246,000
Q4 2017 Jan 30, 2018	SELL	$89.56 - $98.21 $3,134 - $3,437	-35 Reduced 1.32%	2,621 $253,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $185,521 - $236,968	2,656	2,656 $236,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coho Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Coho Partners, Ltd. with notifications on news.

Account